Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIZORIBINE: 363 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
363
Total FAERS Reports
58 (16.0%)
Deaths Reported
206
Hospitalizations
363
As Primary/Secondary Suspect
24
Life-Threatening
9
Disabilities

First Report: 19920922 · Latest Report: 20250106

What Are the Most Common MIZORIBINE Side Effects?

#1 Most Reported
Drug ineffective
36 reports (9.9%)
#2 Most Reported
Off label use
29 reports (8.0%)
#3 Most Reported
Pneumonia
19 reports (5.2%)

All MIZORIBINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 36 9.9% 3 14
Off label use 29 8.0% 3 17
Cytomegalovirus infection 19 5.2% 4 11
Pneumonia 19 5.2% 6 16
Renal impairment 16 4.4% 1 13
Nephrotic syndrome 15 4.1% 1 7
Pyrexia 15 4.1% 3 14
Product use in unapproved indication 14 3.9% 4 4
Urinary tract infection 13 3.6% 4 11
Acute kidney injury 12 3.3% 1 10
Condition aggravated 12 3.3% 0 3
Disseminated intravascular coagulation 12 3.3% 2 12
Hypertension 12 3.3% 1 6
Interstitial lung disease 12 3.3% 6 5
Varicella zoster virus infection 12 3.3% 3 10
Anaemia 11 3.0% 4 7
Influenza 11 3.0% 2 8
Diarrhoea 10 2.8% 0 6
Herpes zoster 10 2.8% 4 6
Covid-19 9 2.5% 2 9

Who Reports MIZORIBINE Side Effects? Age & Gender Data

Gender: 61.9% female, 38.1% male. Average age: 45.5 years. Most reports from: JP. View detailed demographics →

Is MIZORIBINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 2 0 2
2001 1 0 1
2002 2 1 2
2003 1 0 1
2004 1 0 1
2005 2 0 2
2006 2 0 1
2007 3 2 3
2008 5 0 5
2009 3 1 3
2010 2 0 1
2011 9 0 6
2012 9 0 7
2013 6 1 4
2014 9 1 6
2015 13 0 8
2016 14 2 8
2017 21 2 20
2018 10 0 8
2019 8 1 4
2020 2 2 1
2021 4 0 3
2022 7 2 4
2023 7 0 6
2024 3 0 2
2025 1 0 1

View full timeline →

What Is MIZORIBINE Used For?

IndicationReports
Immunosuppressant drug therapy 55
Nephrotic syndrome 42
Rheumatoid arthritis 42
Product used for unknown indication 36
Lupus nephritis 25
Systemic lupus erythematosus 25
Prophylaxis against transplant rejection 22
Renal transplant 15
Glomerulonephritis membranous 11
Immunosuppression 10

MIZORIBINE vs Alternatives: Which Is Safer?

MIZORIBINE vs MOBOCERTINIB MIZORIBINE vs MOCLOBEMIDE MIZORIBINE vs MODAFINIL MIZORIBINE vs MOGAMULIZUMAB MIZORIBINE vs MOGAMULIZUMAB-KPKC MIZORIBINE vs MOLNUPIRAVIR MIZORIBINE vs MOLSIDOMINE MIZORIBINE vs MOMELOTINIB MIZORIBINE vs MOMETASONE MIZORIBINE vs MOMETASONE FUROATE

Official FDA Label for MIZORIBINE

Official prescribing information from the FDA-approved drug label.